Angiogenic factors: role in esophageal cancer, a brief review
- 16 December 2017
- journal article
- review article
- Published by Springer Nature in Esophagus
- Vol. 15 (2) , 53-58
Abstract
Esophageal cancer has an aggressive behavior with rapid tumor mass growth and frequently poor prognosis; it is known as one of the most fatal types of cancer worldwide. The identification of potential molecular markers that can predict the response to treatment and the prognosis of this cancer has been subject of a vast investigation in the recent years. Among several molecules, various angiogenic factors that are linked to the tumor development, growth, and invasion, such as VEGF, HGF, angiopoietin-2, IL-6, and TGF-B1, were investigated. In this paper, the authors sought to review the role of these angiogenic factors in prognosis and hypothesize how they can be used as a treatment target.Keywords
This publication has 50 references indexed in Scilit:
- TGFβ1 and HGF protein secretion by esophageal squamous epithelial cells and stromal fibroblasts in oesophageal carcinogenesisOncology Letters, 2013
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Bevacizumab in Non–Small Cell Lung CancerClinical Cancer Research, 2007
- INTERLEUKIN-6: From Basic Science to Medicine—40 Years in ImmunologyAnnual Review of Immunology, 2005
- Expression of hypoxia-inducible factor (HIF)-1α is associated with vascular endothelial growth factor expression and tumour angiogenesis in human oesophageal squamous cell carcinomaEuropean Journal of Cancer, 2004
- Plasma Level of Transforming Growth Factor β1 Measured from the Azygos Vein Predicts Prognosis in Patients with Esophageal CancerClinical Cancer Research, 2004
- Regulation of angiogenesis by hypoxia: role of the HIF systemNature Medicine, 2003
- Inflammation and cancerNature, 2002
- Stat proteins and oncogenesisJournal of Clinical Investigation, 2002
- Significance of transforming growth factor β1 as a new tumor marker for colorectal cancerInternational Journal of Cancer, 2001